Trademarkia Logo

Canada

C$
Trademark Search in Canada
RYLEMBRA

View On IC.GC.CA

RYLEMBRA
ADVERTISED

on 12 Feb 2025

Last Applicant/ Owned by

ZYUS LIFE SCIENCES INC.

204-407 Downey RoadSaskatoon

SASKATCHEWAN

CA

S7N4L8

Serial Number

2002789 filed on 20th Dec 2019

Correspondent Address

BORDEN LADNER GERVAIS LLP

Bay Adelaide Centre, East Tower22 Adelaide St. WestTORONTO

ONTARIO

CA

M5H4E3

RYLEMBRA

Trademark usage description

pharmaceutical phytochemicals, namely, chemical additives and preparations for use in the manufacture of pharmaceuticals; cannabinoid and protein-base Read More

Classification Information

Class [001]
Pharmaceutical phytochemicals, namely, chemical additives and preparations for use in the manufacture of pharmaceuticals; cannabinoid and protein-based additives for use in the manufacture of pharmaceutical preparations

Classification kind code

11

Class [005]
Pharmaceutical preparations for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis; pharmaceutical preparations, namely, phytotherapeuticals containing cannabinoids and proteins for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis; natural health products for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation, namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis; cannabis substances for the treatment of pain, nausea, epilepsy, multiple sclerosis, diseases associated with inflammation namely, inflammatory muscle diseases and disorders, inflammatory bowel diseases, inflammatory connective tissue diseases and autoimmune diseases, cancer, arthritis, neurological diseases, namely, Alzheimer's, Huntington's Disease, cerebral palsy and neurological disorders, namely, brain injury, spinal cord injury, seizure disorders, Tourette Syndrome, Parkinson's, migraines, motor neuron disease, autism and amyotrophic lateral sclerosis

Classification kind code

11

Mark Details

Serial Number

2002789

Mark Type

Trademark

Legal History

Action TakenStatus
Submitted for opposition 42
on 12th Feb 2025		Advertised
Submitted for opposition 26
on 14th Jan 2025		Approved
Submitted for opposition 27
on 14th Jan 2025		Approval Notice Sent
Submitted for opposition 22
on 28th May 2024		Search Recorded
Submitted for opposition 20
on 28th May 2024		Examiner's First Report
Submitted for opposition 287
on 10th May 2022		Pre-Assessment Letter Sent
Submitted for opposition 31
on 9th Jan 2020		Formalized
Submitted for opposition 1
on 23rd Dec 2019		Created
Submitted for opposition 30
on 20th Dec 2019		Filed